cupure logo
cancertrumpbidenjoediagnosisprostaterevealsprostate cancercancer diagnosiscrash

Biotechnology company Regeneron buying 23andMe for $256 million

Biotechnology company Regeneron buying 23andMe for $256 million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection

Comments

Breaking news